Nyxoah SA Files Form 6-K
Ticker: NYXH · Form: 6-K · Filed: Dec 2, 2024 · CIK: 1857190
| Field | Detail |
|---|---|
| Company | Nyxoah SA (NYXH) |
| Form Type | 6-K |
| Filed Date | Dec 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K
TL;DR
Nyxoah SA filed a routine 6-K, no major news.
AI Summary
Nyxoah SA, a medical device company, filed a Form 6-K on December 2, 2024. The filing is a report of a foreign private issuer and does not contain specific financial details or operational updates beyond its classification and reporting status.
Why It Matters
This filing indicates Nyxoah SA is fulfilling its reporting obligations as a foreign private issuer with the SEC, which is standard procedure for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This is a standard regulatory filing with no new material information disclosed.
Key Players & Entities
- Nyxoah SA (company) — Registrant
- 001-40552 (other) — SEC File Number
- 20241202 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country.
What is Nyxoah SA's primary business?
Nyxoah SA is involved in the Surgical & Medical Instruments & Apparatus industry, SIC code 3841.
When was this Form 6-K filed?
This Form 6-K was filed on December 2, 2024.
Does this filing contain specific financial results?
The provided text of the filing does not contain specific financial results or operational updates.
What is Nyxoah SA's principal executive office address?
Nyxoah SA's principal executive office is located at Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium.
Filing Stats: 446 words · 2 min read · ~1 pages · Grade level 18.4 · Accepted 2024-12-02 16:10:15
Filing Documents
- tm2429828d1_6k.htm (6-K) — 12KB
- tm2429828d1_ex99-1.htm (EX-99.1) — 5KB
- tm2429828d1_ex99-1img001.jpg (GRAPHIC) — 4KB
- 0001104659-24-124576.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NYXOAH SA Date: December 2, 2024 By: /s/ John Landry Name: John Landry Title: Chief Financial Officer